These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 22735065)
1. Current guidelines for cervical cancer screening. Schwaiger C; Aruda M; LaCoursiere S; Rubin R J Am Acad Nurse Pract; 2012 Jul; 24(7):417-24. PubMed ID: 22735065 [TBL] [Abstract][Full Text] [Related]
2. The human papillomavirus in women over 40: implications for practice and recommendations for screening. Montgomery K; Bloch JR J Am Acad Nurse Pract; 2010 Feb; 22(2):92-100. PubMed ID: 20132367 [TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus infection and cervical cancer prevention in Japan and Korea. Konno R; Shin HR; Kim YT; Song YS; Sasagawa T; Inoue M; Park JS Vaccine; 2008 Aug; 26 Suppl 12():M30-42. PubMed ID: 18945412 [TBL] [Abstract][Full Text] [Related]
4. Knowledge, attitude and practice in primary and secondary cervical cancer prevention among young adult Italian women. Donati S; Giambi C; Declich S; Salmaso S; Filia A; Ciofi degli Atti ML; Alibrandi MP; Brezzi S; Carozzi F; Collina N; Franchi D; Lattanzi A; Meda M; Minna MC; Nannini R; Gallicchio G; Bella A; Vaccine; 2012 Mar; 30(12):2075-82. PubMed ID: 22300719 [TBL] [Abstract][Full Text] [Related]
5. Cervical cancer screening among women who attend sexually transmitted diseases (STD) clinics: background paper for 2010 STD Treatment Guidelines. Datta SD; Saraiya M Clin Infect Dis; 2011 Dec; 53 Suppl 3():S153-9. PubMed ID: 22080268 [TBL] [Abstract][Full Text] [Related]
6. Prevalence of high-risk human papillomavirus type 16/18 infection among women with normal cytology: risk factor analysis and implications for screening and prophylaxis. Gupta S; Sodhani P; Sharma A; Sharma JK; Halder K; Charchra KL; Sardana S; Singh V; Sehgal A; Das BC Cytopathology; 2009 Aug; 20(4):249-55. PubMed ID: 19018810 [TBL] [Abstract][Full Text] [Related]
7. Epidemiology of human papillomavirus infection and cervical cancer and future perspectives in Hong Kong, Singapore and Taiwan. Tay SK; Ngan HY; Chu TY; Cheung AN; Tay EH Vaccine; 2008 Aug; 26 Suppl 12():M60-70. PubMed ID: 18945415 [TBL] [Abstract][Full Text] [Related]
8. Recommendations for cervical cancer prevention in Asia Pacific. Garland SM; Cuzick J; Domingo EJ; Goldie SJ; Kim YT; Konno R; Parkin DM; Qiao YL; Sankaranarayanan R; Stern PL; Tay SK; Bosch FX Vaccine; 2008 Aug; 26 Suppl 12():M89-98. PubMed ID: 18945418 [TBL] [Abstract][Full Text] [Related]
9. Impact of pap test compliance and cervical cancer screening intervals on human papillomavirus vaccine acceptance. Ferris DG; Waller J; Dickinson A; McCracken C; Goebel A J Low Genit Tract Dis; 2012 Jan; 16(1):39-44. PubMed ID: 22126831 [TBL] [Abstract][Full Text] [Related]
10. Cervical cancer screening and management practices among providers in the National Breast and Cervical Cancer Early Detection Program (NBCCEDP). Saraiya M; Irwin KL; Carlin L; Chen X; Jain N; Benard V; Montano DE Cancer; 2007 Sep; 110(5):1024-32. PubMed ID: 17628488 [TBL] [Abstract][Full Text] [Related]
11. Australian women's needs and preferences for information about human papillomavirus in cervical screening. McCaffery K; Irwig L J Med Screen; 2005; 12(3):134-41. PubMed ID: 16156944 [TBL] [Abstract][Full Text] [Related]
13. Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone: what screening intervals are physicians recommending? Saraiya M; Berkowitz Z; Yabroff KR; Wideroff L; Kobrin S; Benard V Arch Intern Med; 2010 Jun; 170(11):977-85. PubMed ID: 20548011 [TBL] [Abstract][Full Text] [Related]
14. Assessing the role of education in women's knowledge and acceptance of adjunct high-risk human Papillomavirus testing for cervical cancer screening. Papa D; Moore Simas TA; Reynolds M; Melnitsky H J Low Genit Tract Dis; 2009 Apr; 13(2):66-71. PubMed ID: 19387125 [TBL] [Abstract][Full Text] [Related]
15. Incorporating human papillomavirus testing into cytological screening in the era of prophylactic vaccines. Almonte M; Sasieni P; Cuzick J Best Pract Res Clin Obstet Gynaecol; 2011 Oct; 25(5):617-29. PubMed ID: 21683657 [TBL] [Abstract][Full Text] [Related]
16. A qualitative analysis of South African women's knowledge, attitudes, and beliefs about HPV and cervical cancer prevention, vaccine awareness and acceptance, and maternal-child communication about sexual health. Francis SA; Battle-Fisher M; Liverpool J; Hipple L; Mosavel M; Soogun S; Mofammere N Vaccine; 2011 Nov; 29(47):8760-5. PubMed ID: 21855591 [TBL] [Abstract][Full Text] [Related]
17. Young women's perspectives on cervical cancer prevention in Appalachian Kentucky. Head KJ; Cohen EL Qual Health Res; 2012 Apr; 22(4):476-87. PubMed ID: 22068039 [TBL] [Abstract][Full Text] [Related]
18. Does HPV vaccination affect women's attitudes to cervical cancer screening and safe sexual behaviour? Mather T; McCaffery K; Juraskova I Vaccine; 2012 May; 30(21):3196-201. PubMed ID: 22425789 [TBL] [Abstract][Full Text] [Related]
19. Do cervical cancer screening patient information leaflets meet the HPV information needs of women? Hall B; Howard K; McCaffery K Patient Educ Couns; 2008 Jul; 72(1):78-87. PubMed ID: 18372144 [TBL] [Abstract][Full Text] [Related]
20. ACS/ASCCP/ASCP guidelines for the early detection of cervical cancer. Fontaine PL; Saslow D; King VJ Am Fam Physician; 2012 Sep; 86(6):501, 506-7. PubMed ID: 23062041 [No Abstract] [Full Text] [Related] [Next] [New Search]